Filtered By:
Condition: Ischemic Stroke
Drug: Cilostazol
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 155 results found since Jan 2013.
Vessel Wall Changes on Serial High-Resolution MRI and the Use of Cilostazol in Patients With Adult-Onset Moyamoya Disease
CONCLUSIONS: Adult-onset MMD induces progressive shrinkage of large intracranial arteries, which cilostazol treatment may prevent. Further randomized clinical trials are warranted.TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02074111.PMID:36367058 | PMC:PMC9669557 | DOI:10.3988/jcn.2022.18.6.610
Source: Journal of Clinical Neurology - November 11, 2022 Category: Neurology Authors: Jae Youn Kim Hyung Jun Kim Eun-Hyeok Choi Kwang Hyun Pan Jong-Won Chung Woo-Keun Seo Gyeong-Moon Kim Tae Keun Jee Je Young Yeon Jong-Soo Kim Seung-Chyul Hong Min-Jung Seong Jihoon Cha Keon Ha Kim Pyoung Jeon Oh Young Bang Source Type: research
Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation
CONCLUSIONS: Cilostazol-based dual antiplatelet therapy could be recommended as an effective and safe therapy regimen among patients undergoing intracranial or extracranial artery stent implantation.PMID:36328566 | DOI:10.5551/jat.63632
Source: Journal of Atherosclerosis and Thrombosis - November 3, 2022 Category: Cardiology Authors: Hui Liu Tengfei Shao Tao Yang Di Li Huan Wang Yue Cheng Tingzheng Zhang Jinping Zhang Source Type: research
